#BiomarkerTesting
#LungCancer screening at scale, equal access to #BiomarkerTesting across Europe and greater awareness of the disease. Lung Cancer Europe put these priorities to Tilly Metz, newly elected Vice-President of the European Parliament, today. A very well received meeting.
November 17, 2026 at 1:35 PM
Biomarkers can provide important clues about a tumor and help doctors identify the best treatment options for their patients.

Learn more about how biomarkers can open doors to more personalized care. https://www.komen.org/blog/know-more-genomic-testing/

#CancerBiomarker #BiomarkerTesting #CBAD26
November 12, 2026 at 7:50 PM
This Cancer Biomarker Awareness Day, we’re helping to spread the word on #BiomarkerTesting and how it can be a crucial tool in a patient’s cancer care experience. #CBAD26

Hear more: youtu.be/fY2hgLMZfRI
November 12, 2026 at 4:33 PM
🚨 Advanced practitioners: What would support YOUR role in applying #BiomarkerTesting to patient care?

On #CancerBiomarkerAwarenessDay, we're recognizing clinicians who bring precision oncology into practice.

👉 Take our research survey: thejacksonlaboratory.qualtrics.com/jfe/form/SV_...

#CBAD26
November 12, 2026 at 5:01 PM
Our updated Checklist to Accessing Biomarker Testing walks you through questions to ask your health care team, what to know about insurance coverage, how to appeal a denial, and where to find financial help if needed.

Read now: TriageCancer.org/Checklist-BiomarkerTesting
October 14, 2026 at 2:04 PM
Exciting day for cancer care in Delaware! Senate Bill 120 expanding insurance coverage for #BiomarkerTesting was signed into law! TY to the legislators, advocacy organizations & most importantly patient advocates for sharing their stories 🧬🩺❤️!
September 9, 2026 at 12:11 AM
Please join us in welcoming Tanner’s Hope as the newest member of the #MyTumorID Affiliate Program.

They're partnering with us to expand education on #biomarkertesting and #clinicaltrials — empowering brain tumor patients to make informed decisions.
September 4, 2026 at 11:25 AM
As #BiomarkerTesting grows in #PrecisionOncology, understanding how tumor findings inform hereditary cancer risk assessment is critical.

This interactive @jacksonlab.bsky.social course helps GCs strengthen interpretation of biomarker testing using real-world clinical scenarios. #GeneChat
January 12, 2026 at 1:27 PM
JAX and MCGI sit at the crossroads of clinical practice and emerging research — where innovation meets implementation. This work is helping make precision oncology more accessible to patients and clinicians across Maine and beyond.

#BiomarkerTesting #PrecisionOncology #GeneticCounseling
December 11, 2025 at 12:44 PM
Did you miss @jacksonlab.bsky.social's 🆓 Precision Oncology 101: Short Lessons for Busy Clinicians webinar series?

Watch ➡️ education.clinical.jax.org/page/precisi...

Each 30-minute recording provides insights into #BiomarkerTesting for therapeutic decision-making for #oncology providers. #OncoSky
December 26, 2024 at 1:14 PM
Curious why biomarker timing matters in NSCLC treatment? For Cancer Biomarker Awareness Day, check out this past Lung Cancer Considered discussion: bit.ly/489wK2Z
#biomarkertesting
The Importance of Waiting for Biomarker Results in NSCLC | IASLC
Biomarkers are essential in lung cancer treatment, but they remain underutilized. In addition, clinicians and patients have to wait for those results before sta ...
bit.ly
November 14, 2025 at 12:11 AM
Patrick lives in Virginia, with family history he is at increased risk. Virginia needs to do better.
Biomarker testing can improve cancer treatment outcomes, people in Virginia do not have equal access, even with insurance. bit.ly/biomarker-ad...
#biomarkertesting #ColorectalCancerAwarenessMonth
March 12, 2025 at 3:01 PM
Biomarker testing can improve cancer treatment outcomes, but many Americans do not have equal access, even through insurance. Join me and advocate for access. To learn how, download these instructions from the CC Alliance: bit.ly/biomarker-ad...
#biomarkertesting #ColorectalCancerAwarenessMonth
March 11, 2025 at 2:46 PM
The U.S. must expand access to and coverage for #NewbornScreening, #BiomarkerTesting and rapid #WholeGenomeSequencing, which have been crucial for the early diagnosis of certain #RareDiseases, says NORD Analyst Mason Barrett. He outlines what's needed to get there: thepathologist.com/issues/2025/...
Innovating in Rare Diseases: Together!
A roundtable discussion on the rare disease landscape and diagnostic directions
thepathologist.com
March 28, 2025 at 8:22 PM
Learn more about #biomarkertesting through LUNGevity’s “No One Missed” campaign noonemissed.org
No One Missed | No One Missed Campaign
noonemissed.org
November 19, 2024 at 12:40 AM
All people with #NSCLC should get #biomarkertesting at diagnosis and at progression.
I didn't understand until a year later the true importance of what she had done for me! Now I try to get the word out to all patients, especially in Canada where access is inconsistent.
November 19, 2024 at 12:39 AM
Thank you for the opportunity to highlight the importance of #biomarkertesting in #NSCLC to ensure that patients get the treatment that is right for them. #LungCancerAwarenessMonth #LCSM

www.linkedin.com/posts/daiich...
Daiichi Sankyo US on LinkedIn: #lungcancerawarenessmonth #lcam
Biomarker testing has a vital role in the treatment of cancer. It ensures the right medicine reaches the right patient at the right time, embodying the hope of…
www.linkedin.com
November 18, 2024 at 6:28 PM
#BiomarkerTesting helps guide #LungCancer treatment—but not all tests capture the full picture.

Tissue testing remains the gold standard for identifying actionable mutations.

Hear more from Dr. Josh Sabari in this clip. ⬇️

Still have questions? Call 800-298-2436 or email support@go2.org.
March 27, 2026 at 7:22 PM
FDA update‼️

Hernexeos (zongertinib) is now approved as a first-line treatment for advanced non-squamous (NSCLC) with a HER2 activating mutation.

Another example that #BiomarkerTesting can directly shape treatment options. 🙌

Read the details: go2.org/blog/fda-exp...
February 27, 2026 at 5:37 PM